AAD's Dialogues in Dermatology

221 Episodio

1. March JAAD: Sex Differences in Initial Treatment for Genital Extramammary Paget Disease in the United States: A Systematic Review

   Pubblicato: 5/4/2023
2. April JAAD: A Propensity Score Matched Cohort Study Identifying an Association of Acne, But Not Oral Antibiotic or Isotretinoin Use, With Risk of Incident Inflammatory Bowel Disease

   Pubblicato: 5/4/2023
3. December JAAD: Variations in Genetics, Biology and Phenotype of Cutaneous Disorders in Skin of Color. Part I: Genetic Biological, and Structural Differences in Skin of Color

   Pubblicato: 5/4/2023
4. Bonus: AAD 2023 Election: President-Elect (Dr. Susan Taylor) and Vice-President Elect (Dr. Kevin Cooper)

   Pubblicato: 4/4/2023
5. Bonus: Getting to Know Your President and Vice President

   Pubblicato: 29/3/2023
6. Bonus: Gaps in Research in Psoriasis (Sponsored by Bristol Myers Squibb)

   Pubblicato: 29/3/2023
7. Practice Management Series: Understanding patients’ rights to access medical records

   Pubblicato: 27/3/2023
8. JAAD International Series: Q1 2023 Issue in Review

   Pubblicato: 15/3/2023
9. February JAAD: Lentigo maligna melanoma mapping using reflectance confocal microscopy correlates with staged excision: A prospective study

   Pubblicato: 8/3/2023
10. Bonus: AAD 2023 Election: President-Elect Candidate Interview (Dr. Andrew Weinstein)

    Pubblicato: 21/2/2023
11. Bonus: AAD 2023 Election: President-Elect Candidate Interview (Dr. Susan Taylor)

    Pubblicato: 21/2/2023
12. Bonus: The History of Dermatology

    Pubblicato: 9/2/2023
13. Bonus: Categorizing Psoriasis Severity (Sponsored by Bristol Myers Squibb)

    Pubblicato: 8/2/2023
14. Guidelines Series: Guidelines of Care for the Management and Treatment of Pediatric Psoriasis

    Pubblicato: 8/2/2023
15. Bonus: Advances in the Understanding of Alopecia Areata Pathogenesis (Sponsored by Eli Lilly and Company)

    Pubblicato: 8/2/2023
16. Bonus: Hairstyling and Alopecia - What Dermatologists Need to Know (Sponsored by Eli Lilly and Company)

    Pubblicato: 8/2/2023
17. Bonus: Transition to Retirement and How to Sell Your Practice

    Pubblicato: 2/2/2023
18. Bonus: Actinic Keratosis (Sponsored by Almirall)

    Pubblicato: 23/1/2023
19. January JAAD: Deucravacitnib versus placebo and apremilast in moderate to severe plaque psoriasis: efficacy and safety results from the 52-week randomized, double-blinded, placebo-controlled hase 3 PO

    Pubblicato: 11/1/2023
20. Guidelines Series: Psoriasis Topicals and Non-Biologic Care Improvement Strategies

    Pubblicato: 9/1/2023